Page 256 - IJB-10-5
P. 256

International Journal of Bioprinting                                  3D printed hydrogels for tumor therapy




























































            Figure 9. Photothermal effect and controlled DOX release behavior of printed hydrogels. (A, B) Temperature changes of 3D-printed GelMA, HAp/GelMA,
                                                                                              2
                                                                                                          2
            MgHAp/GelMA, and MgHAp/GelMA-PDA hydrogels under the irradiation of 808 nm NIR laser at power densities of 0.5 W/cm  (A) and 1.0 W/cm (B).
            (C) Infrared thermal images of 3D-printed GelMA, HAp/GelMA, MgHAp/GelMA, and MgHAp/GelMA-PDA hydrogels after being irradiated by NIR
            laser for 3 min. (D) In vitro DOX release curves of MgHAp/GelMA-PDA@DOX hydrogels with (0.5 and 1.0 W/cm ) and without NIR laser irradiation (pH
                                                                                    2
            7.4, PBS). (E) In vitro DOX release curves of MgHAp/GelMA-PDA@DOX hydrogels in pH 4.5 and 7.4 buffer solutions.
            3.5. In vitro antitumor efficiency                 GelMA-PDA@DOX hydrogels combined with NIR laser
            Chemotherapy assisted by PTT enables the controlled   irradiation were employed to  investigate  the  in vitro
            release of DOX on demand while simultaneously providing   antitumor efficiency. As shown in Figure 10A, after being
            hyperthermia, showing great synergy for tumor treatment.   cultured for 4 and 24 h, many bone tumor cells were found
            Many studies have revealed that NIR laser irradiation   dead in the MgHAp/GelMA-PDA+NIR, MgHAp/GelMA-
            could cause the local temperature within the range of 42–  PDA@DOX,  and  MgHAp/GelMA-PDA@DOX+NIR
            50°C and thus provide hyperthermia and synergistically   groups. Moreover, Figure 10B indicates that the cell survival
            stimulate DOX release to improve anticancer therapy. 4,9,65   rates of MG63 cells in the MgHAp/GelMA-PDA, MgHAp/
            Therefore,  in  the  current  study,  3D-printed  MgHAp/  GelMA-PDA+NIR, MgHAp/GelMA-PDA@DOX,  and


            Volume 10 Issue 5 (2024)                       248                                doi: 10.36922/ijb.3526
   251   252   253   254   255   256   257   258   259   260   261